US drug approvals
55 approvals with a product on the US market
- Tranexamic Acid ANDA218896 · approved 2 Jun 2025
- Doxycycline Hyclate ANDA217854 · approved 23 Jul 2024
- Docetaxel ANDA216677 · approved 28 Feb 2024
- Lidocaine Hydrochloride ANDA215132 · approved 9 Jun 2022
- Verapamil Hydrochloride ANDA215829 · approved 17 Mar 2022
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.